HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Patrice Prognon Selected Research

tetraphenylporphyrin

2/2013Plasma distribution of tetraphenylporphyrin derivatives relevant for Photodynamic Therapy: importance and limits of hydrophobicity.
10/2011Diprotonation process of meso-tetraphenylporphyrin derivatives designed for photodynamic therapy of cancers: from multivariate curve resolution to predictive QSPR modeling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Patrice Prognon Research Topics

Disease

8Neoplasms (Cancer)
07/2018 - 08/2003
5Fabry Disease (Fabry's Disease)
12/2015 - 07/2005
2Retinoblastoma (Glioblastoma, Retinal)
02/2013 - 10/2012
2Lysosomal Storage Diseases (Lysosomal Storage Disease)
03/2007 - 01/2006
1Peripheral Arterial Disease
08/2021
1Aortic Valve Stenosis (Aortic Stenosis)
04/2020
1Hematologic Neoplasms (Hematological Malignancy)
07/2018
1Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy)
01/2011
1Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
01/2011
1Lipomatosis
06/2010
1Iliac Aneurysm
11/2008
1Rupture
11/2008
1Abdominal Aortic Aneurysm
11/2008
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2008
1Endoleak
11/2008
1Inborn Errors Metabolism (Inborn Errors of Metabolism)
03/2007
1Opioid-Related Disorders (Opiate Addiction)
06/2004

Drug/Important Bio-Agent (IBA)

31-phenyl-3,3-dimethyltriazene (PDT)IBA
10/2012 - 08/2003
3Biological ProductsIBA
01/2006 - 12/2004
2Pharmaceutical PreparationsIBA
08/2021 - 10/2006
2EnzymesIBA
12/2015 - 03/2007
2GalactosidasesIBA
12/2015 - 03/2007
2tetraphenylporphyrinIBA
02/2013 - 10/2011
2Photosensitizing Agents (Photosensitizers)IBA
10/2012 - 08/2003
2alpha-Galactosidase (Beano)IBA
01/2006 - 07/2005
2PorphyrinsIBA
12/2004 - 08/2003
1Monoclonal AntibodiesIBA
07/2018
1Hexadimethrine BromideIBA
09/2015
1Cetuximab (Erbitux)FDA Link
09/2015
1Bevacizumab (Avastin)FDA Link
09/2015
1Trastuzumab (Herceptin)FDA Link
09/2015
1Rituximab (Mabthera)FDA Link
09/2015
1Blood Proteins (Serum Proteins)IBA
02/2013
1Lipoproteins (Lipoprotein)IBA
02/2013
1Adrenal Cortex Hormones (Corticosteroids)IBA
06/2010
1EverolimusFDA Link
06/2010
1Prednisone (Sone)FDA LinkGeneric
06/2010
1GlycosphingolipidsIBA
07/2005
1globotriaosylceramide (globotriosylceramide)IBA
07/2005
1galabiosylceramideIBA
07/2005
1Methadone (Dolophine)FDA LinkGeneric
06/2004

Therapy/Procedure

5Photochemotherapy (Photodynamic Therapy)
10/2012 - 08/2003
3Drug Therapy (Chemotherapy)
12/2010 - 11/2008
2Therapeutics
09/2015 - 11/2008
1Drug-Eluting Stents
08/2021
1Transcatheter Aortic Valve Replacement
04/2020
1Conservative Treatment
10/2012
1Enzyme Replacement Therapy
01/2011
1Stents
11/2008